DrugPatentWatch Database Preview
Mechanism of Action: Bile-acid Binding Activity
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
Drugs with Mechanism of Action: Bile-acid Binding Activity
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Daiichi Sankyo Inc | WELCHOL | colesevelam hydrochloride | BAR, CHEWABLE;ORAL | 210895-001 | Apr 3, 2019 | RX | Yes | Yes | Start Trial | Start Trial | Start Trial | ||||
| Daiichi Sankyo | WELCHOL | colesevelam hydrochloride | FOR SUSPENSION;ORAL | 022362-001 | Oct 2, 2009 | DISCN | Yes | No | Start Trial | Start Trial | Y | Start Trial | |||
| Daiichi Sankyo | WELCHOL | colesevelam hydrochloride | FOR SUSPENSION;ORAL | 022362-002 | Oct 2, 2009 | AB | RX | Yes | Yes | Start Trial | Start Trial | Y | Start Trial | ||
| Daiichi Sankyo | WELCHOL | colesevelam hydrochloride | TABLET;ORAL | 021176-001 | May 26, 2000 | AB | RX | Yes | Yes | Start Trial | Start Trial | Y | Start Trial | ||
| Upsher Smith Labs | PREVALITE | cholestyramine | POWDER;ORAL | 073263-001 | Feb 22, 1996 | AB | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| Upsher Smith Labs | PREVALITE | cholestyramine | POWDER;ORAL | 073263-002 | Oct 30, 1997 | AB | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
